Smith R R, Hamilton S R, Boitnott J K, Rogers E L
Am J Surg Pathol. 1984 Aug;8(8):563-73. doi: 10.1097/00000478-198408000-00001.
The clinical and pathologic features of carcinoma arising in Barrett's esophagus were studied in resection specimens from 26 patients. White males predominated (73%). A history of symptomatic gastroesophageal reflux was frequently absent, being elicited in only eight of 14 patients (57%) with a carefully obtained history at the time of presentation with carcinoma. Survival was relatively short with a median survival of 23 +/- 5 months, and only three patients had a disease-free survival longer than 2 years. A pathologic spectrum of carcinoma was found: differentiation ranged from well to poorly differentiated in the 20 patients with a single adenocarcinoma; two separate carcinomas were found in four patients; and a spectrum of differentiation in a single tumor was found in the other two cases, one an adenocarcinoid tumor and the other an adenosquamous carcinoma. The tumors were generally far advanced, with extension through the esophageal wall in 23 of 26 cases (88%) and metastases to lymph nodes in 17 of 24 cases (71%). Epithelial dysplasia, including carcinoma in situ in some cases, was found in Barrett's mucosa adjacent to the tumor in all 26 patients. Our findings suggest that a surveillance program for dysplasia in patients known to have Barrett's esophagus is warranted in an attempt to improve the outcome. However, the impact of surveillance on the incidence of Barrett's carcinoma may be lessened by its frequent occurrence in patients with asymptomatic gastroesophageal reflux.
对26例患者手术切除标本中Barrett食管来源的癌的临床和病理特征进行了研究。白人男性占多数(73%)。有症状的胃食管反流病史常常不存在,在14例出现癌时经仔细询问病史的患者中,只有8例(57%)有该病史。生存期相对较短,中位生存期为23±5个月,只有3例患者无病生存期超过2年。发现了癌的病理谱:20例单一腺癌患者中,分化程度从高分化到低分化不等;4例患者中有两个独立的癌;另外两例中,在单个肿瘤中发现了分化谱,一例为腺类癌,另一例为腺鳞癌。肿瘤通常进展期,26例中有23例(88%)肿瘤穿透食管壁,24例中有17例(71%)有淋巴结转移。在所有26例患者肿瘤旁的Barrett黏膜中均发现上皮发育异常,部分病例包括原位癌。我们的研究结果提示,对已知有Barrett食管的患者进行发育异常监测计划是必要的,以期改善预后。然而,由于Barrett癌常发生于无症状胃食管反流患者,监测对Barrett癌发病率的影响可能会减弱。